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Abstract The peptide hormone somatostatin inhibits glucose- 
induced insulin secretion in the rat insulinoma RINm5F cells by 
inhibition of voltage-gated calcium channels. Here we used micro- 
injection of antisense oligonucleotides directed against subtypes 
of G-protein subunits to determine the subunit composition in- 
volved in somatostatin-induced inhibition of voltage-gated cal- 
cium channels in RINmF5 cells. Injection of antisense oligonucle- 
otides annealing to the respective mRNA of Gc~o2, GI31 and G~/3 
reduced the somatostatin-induced inhibition of calcium channels 
in these cells. Injection of antisense oligonucleotides directed 
against other G-protein subunits did not, suggesting that in 
RINm5F cells the somatostatin receptor couples to a G protein 
of G~o2/$fg 3 composition. By using a selective agonist of type 2 
somatostatin receptors (SSTR 2) NC 8-12, we identified this 
receptor as the subtype coupling to calcium channels in RINmSF 
cells. 
Key words'." Somatostatin receptor; G-protein heterotrimer; 
R INm5F microinjection; Antisense oligonucleotide 
I. Introduction 
Somatostatin, a peptide hormone of 14 or 28 aminoacids, 
exerts many physiological effects on endocrine and nerve cells. 
It is the major physiological inhibitor of growth hormone re- 
lease from the pituitary and of insulin and glucagon secretion 
from the pancreas. The intracellular effects caused by somato- 
statin are mediated by a family of five related receptors which 
are members of the superfamily of  heptahelical receptors (for 
reviews see [1-6]). These receptors interact with heterotrimeric 
guanine nucleotide-binding proteins (G proteins). G proteins 
represent a family of proteins mediating signal transduction 
from the outside of the cell to the cytoplasm by interacting with 
receptor and effector proteins. They are composed of three 
subunits, ~, fl and ),, of which at least 23 different ~ forms (G~) 
(including splice variants), 5 different fl forms (Gfl) and 11 
different ~' forms (GT) exist. The cellular effects mediated by 
somatostatin are inhibition of adenylyl cyclase, stimulation of 
K ÷ channels and inhibition of voltage-gated Ca 2+ channels. All 
effects are mediated by pertussis toxin (PTX)-sensitive G pro- 
teins of the Gi/o family. In the insulin-secreting cell lines HIT 
and RINm5F, somatostatin inhibits voltage-gated Ca 2÷ chan- 
nels suggesting this as one mechanism by which sornatostatin 
inhibits glucose-induced insulin release in these cell lines [7,8]. 
Previously, we used microinjection of antisense oligonucleo- 
tides to identify the subunit composition of  heterotrimeric 
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G proteins mediating modulation of Ba 2+ current hrough volt- 
age-gated Ca 2÷ channels (Ic,). In GH 3 cells the M4 muscarinic 
receptor couples to the G protein trimer consisting of ao~f13~'4, 
the somatostatin receptor uses the trimer C~ofl~)' 3, and the 
galanin receptor couples to the trimers Cto~fl2~" 2 and ~ofl3~'4. The 
latter receptor uses the same trimers to inhibit voltage-gated 
Ca 2+ channels in the insulinoma cell line R INm5F [9 12]. Here 
we used the same method to determine the subunit composition 
of the G proteins involved in inhibition of voltage-gated Ca 2+ 
channels by somatostatin i R INm5F cells. 
2. Materials and methods 
2.1. Materials 
Rat galanin was purchased from Saxon Biochemicals (Hannover, 
Germany), pertussis toxin was from List Biological Laboratories 
(Campbell, USA), somatostatin, [ethylenebis (oxyethyleneni- 
trilo)]tetraacetic a id (EGTA) and 1,2-bis(2-aminophenoxy)ethane- 
N,N,N',N'-tetraacetic a id (BAPTA) were from Sigma (Deisenhofen, 
Germany). All other chemicals were from Sigma (Deisenhofen, Ger- 
many) or Merck (Darmstadt, Germany). Galanin and somatostatin 
were used at the final concentrations of 500 nM and 1/IM, respectively. 
2.2. Cell culture 
The insulin-secreting cell line RINm5F was obtained from the Amer- 
ican Type Culture Collection (Rockville, USA) and was cultured using 
RPMI-1640 medium containing 10% fetal calf serum, 2 mM L-glutam- 
ine, 0.1 mg/ml streptomycin and 100 units/ml penicillin in an atmos- 
phere of 5% CO2 in air. One day prior to microinjection, trypsinized 
cells were seeded at a density of 200-1000 cells/mm 2 in plastic Petri 
dishes containing lass slides imprinted with squares for localization of 
injected cells. If indicated, PTX was added to the medium at a concen- 
tration of 100 ng/ml 24 h prior to experiments. 
2.3. Oligonucleotides and inection 
The sequences ofoligonucleotides were chosen by sequence compar- 
ison and multiple alignment using MacMolly Tetra software (Soft 
Gene, Berlin, Germany). The base sequences of rat mRNAs are not 
known for all G-protein subunits tudied here. Therefore, we used the 
statistical approach of preferred codon usage in the rat to obtain the 
most likely sequences. For details ee Kalbrenner et al. [12] and Degtiar 
et al. (submitted). The oligonucleotide named anti-~co mis able to anneal 
to a nucleotide sequence common to the mRNAs of all PTX-sensitive 
G proteins; it is reverse-complementary to sense-C~co m. These oligonucle- 
otides as well as anti-~ocom, anti-Cticom, anti-~o~, anti-~o2, anti-~, anti-cq ~ 
and anti-~z are identical to those used in previous tudies [9,12,13]. The 
oligonucleotides sense-t3, anti-t,, anti-fl2, anti-t3, anti-t4, anti-y~, anti- 
Y2, anti-~'3, anti-y4 were also used before [I0-12]. Oligodesoxyribonucle- 
otides were synthesized in a DNA synthesizer (Milligen, model 8600); 
chimeric phosphorothioate-phosphodiester oligodesoxyribonucleo- 
tides were synthesized using the method described by Iyer et al. [14]. 
Injections of oligonucleotides were performed by using a manual injec- 
tion system (Eppendorf, Hamburg, Germany). The injection solution 
routinely contained 10 /IM oligonucleotides in water; use of other 
concentrations (5 or 15 ruM) for some experiments did not influence the 
results. Increases in nuclear and entire cell volumes were used as a visual 
control for successful injection (presumably 10-20 fl were injected). To 
measure microinjection efficiency, cells were injected with a 10 /tM 
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solution offluorescein sothiocyanate (FITC)-marked oligonucleotides. 
The fluorescence signal was observed for two days in the nuclei of about 
90% of injected cells. Following injection, cells were usually cultured 
for 44~48 hours before lectrophysiological measurements. About 20 
60% of the injected cells were suitable for electrophysiological measure- 
ments with respect to leak, Ic~ amplitude and stability. 
2.4. Electrophysiological measurements and data analysLs" 
Glass slides with injected cells were transferred into a perfusion 
chamber (0.2 ml volume, 4 ml/min perfusion rate) mounted on an 
inverted microscope. Whole-cell membrane currents were measured at 
37°C according to Hamill et al. [15], using a List LM/EPC7 patch- 
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clamp amplifier (List Electronics, Darmstadt, Germany). Patch pipettes 
were prepared from glass capillaries (Jencons, Leight Buzzard, UK); the 
average resistance of the pipettes was 2.5 3.5 M[). The series resist- 
ance was compensated by 40-70%. The mean capacitiy of the RINm5F 
cells was 13.3 _+ 3.9 pF (±S.D., n = 142). Pipettes were filled with Cs*- 
containing internal solutions in order to block K + conductance (solu- 
tion II: 125 mM CsCI, 1 mM MgC12, 3 mM MgATR 10 mM EGTA, 
10 mM HEPES, pH 7.4 at 37°C, or solution 12 containing: 115 mM 
CsCI, 1 mM MgC12, 3 mM MgATR 20 mM BAPTA, 10 mM HEPES, 
pH 7.4 at 37°C). Before and after an experiment, cells were superfused 
with extracellular solution El (140 mM NaCI, 5.4 mM KCI, 1.8 mM 
CaCI> 1.0 mM MgC12, 10 mM glucose, 10 mM HEPES, pH 7.4 at 
37°C). The whole-cell currents through voltage-gated Ca 2+ channels 
@,3 were measured using Ba 2÷ as divalent charge carrier in solution E2 
(10 mM BaCI> 1 mM MgCI2, 5.4 mM CsCI, 10 mM glucose, 125 mM 
N-methyl-D-glucamine, 10mM HEPES, pH 7.4 at 37°C). The maximal 
amplitude of Ba 2+ currents was recorded uring 20 ms long voltage 
pulses from the holding potential of -80 mV to 0 mV; the stimulation 
rate was 0.5 Hz. The Ba 2+ current amplitude was determined as peak 
inward current. To take into account run-down of channels, the control 
current was determined as mean value of Ba 2÷ current amplitudes 
before somatostatin application and after washout of the hormone. The 
inhibition of Ba 2+ current by somatostatin was determined asdifference 
(in percent) between the peak current amplitude of the control current 
and the peak current amplitude (reached after 6 10 s) during superfu- 
sion of the cells with hormone. The significance of the results was 
determined using Student's t-test assuming a Gaussian distribution of 
data. Standard errors are given as S.E.M. if not otherwise indicated. 
3.  Resu l ts  and  d iscuss ion  
In order to identify the heterotrimeric G proteins coupling 
somatostatin receptors to voltage-gated Ca 2+ channels in the rat 
insulinoma cell line RINm5F, we injected modified antisense 
oligonucleotides directed against subtypes of G-protein c~, fl 
and 7 subunits into the nuclei of  these cells (Fig. 1). Oligonucle- 
otides carried two phosphorothioate-l inked nucleotides at ei- 
ther end with phosphodiester bonds between the other nucleo- 
tides. Two days after injection, we measured whole cell Ba 2+ 
currents. Somatostatin hibited the Ba 2+ current hrough volt- 
age-gated Ca2+channels (Ic,) by 19% in mean. The same mean 
inhibition was measured in cells injected with antisense oligonu- 
cleotides complementary to the mRNAs  encoding for the PTX- 
insensitive G proteins G~4 (anti-~14) and G~5 (anti-cq5) (Fig. 
1A). Injection of a mixture of antisense oligonucleotides di- 
rected against he other PTX-insensitive G proteins G~q, G~ 
and Gc~, (anti-~q+ll+z) also did not influence inhibition of Ica by 
somatostatin. Pretreatment of R INm5F cells with pertussis 
toxin (100 ng/ml for 24 h) reduced inhibition of Ica in the same 
batch of cells from 16% to 5%, Out of the family of PTX 
Fig. 1. Somatostatin-induced Ca 2÷ channel inhibition in RINm5F cells 
injected with antisense oligonucleotides directed against the mRNAs of 
G-protein c~, fl and Y subunits. Ca 2. channel inhibition is shown as 
relative inhibition of the Ba 2+ current (in%) during superfusion of cells 
with 1 #M somatostatin. The whole cell Ba 2+ current was measured 
48 72 hours after injection of the cells with oligonucleotides. Numbers 
in parentheses indicate the number of cells measured for each oligonu- 
cleotide. Oligonucleotide s quences were published previously [9-13]. 
(A) Ba 2+ current inhibition of RINm5F cells injected with antisense 
oligonucleotides directed against subtypes of ~ subunit. PTX indicates 
cells treated for 24 hours with 100 ng/ml pertussis toxin before measure- 
ment of Ba 2* currents. (B) Ba 2+ current inhibition of RINm5F cells 
injected with antisense oligonucleotides directed against subtypes offl 
subunit. (C) Ba 2+ current inhibition of RINm5F cells injected with 
antisense oligonucleotides directed against subtypes of y subunit. 
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Fig. 2. Recordings of whole cell Ba 2÷ currents in RINm5F cells in the presence of galanin and somatostatin. I  each panel, current races are shown 
for one cell, each, superfused with either hormone at 44 hours after injection with antisense oligonucleotides anti-C~o~ r anti-c%2. Each cell was 
superfused with galanin (G, 500 nM) and somatostatin (S,1/dM). Traces 1 and 4 are control currents; traces 2 and 5 represent Ba 2. currents during 
superfusion with hormone; traces 3 and 6 represent currents after washing out the agonist. In this experiment, we obtained similar data with 12 anti-C~o~ 
injected cells and 5 anti-C~o2 injected cells; similar data were obtained in additional experiments. 
sensitive G~/o proteins the c~ subunits of Gil, G~ 2, Go~ and Go2 
are expressed in RINmF5 cells, as shown by Western blots with 
specific antibodies [8]. Cells injected with antisense oligonucle- 
otides directed against a common sequence of all three subtypes 
of c~ subunits of the Gi proteins (anti-~om) showed unchanged 
somatostatin-induced inhibition of Ica. The same holds true for 
cells injected with antisense oligonucleotides which are de- 
signed to anneal selectively to the mRNA coding for the G~ol 
subunit of G proteins (anti-c%0. In contrast, cells injected with 
antisense oligonucleotides annealing to the GC~o2 subunit (anti- 
~o2) showed reduced inhibition of Ica by somatostatin com- 
pared to control cells (8% vs. 19%, see Fig. 1A). These results 
indicate that the G protein that mediates the inhibition of volt- 
age-gated Ca 2÷ channels by somatostatin receptors in RINm5F 
cells includes the GCto2 subunit. In cells injected with antisense 
oligonucleotides annealing to the mRNA encoding the fl~ sub- 
units of G proteins (anti-fl0, the sornatostatin-induced inhibi- 
tion of lc~ was significantly reduced compared to cell injected 
with antisense oligonucleotides directed against he f12, f13 and 
f14 subunits of G proteins (anti-fl2, anti-fl3 and anti-fl4, respec- 
tively) (Fig. 1B). Among cells injected with antisense oligonu- 
cleotides annealing to 7-subunit mRNAs only cells injected 
with those directed against the Y3 subunit (anti-T3) exibited 
reduced Ica inhibition by somatostatin; cells injected with anti- 
sense oligonucleotides directed against he Tl, 72, Y4, 75 and Y7 
subunits (anti-y~, ant-y> anti-y4, anti-y5 and anti-yT, respec- 
tively) displayed a regular degree of somatostatin-induced inhi- 
bition of Ic, (Fig. 1C) when compared to non-injected cells (see 
Fig. IA). 
An important question in using antisense oligonucleotides is 
the specificity of an effect reached with an antisense oligonucle- 
otide. We previously showed by immunofluorescence studies 
that in RINm5F cells injected with anti-~o~ and anti-c%2 ol- 
igonucleotides the expression of the G~o~ and G~o2 proteins, 
respectively, is selectively inhibited [12]. In addition to the pro- 
tein expression, we probed the selectivity of the antisense ol- 
igonucleotides on the functional evel. In cells injected with 
anti-~o2 oligonucleotides, the somatostatin-induced inhibition 
of Ica was largely inhibited. In contrast, in the same cells the 
inhibition of Ica by galanin was unchanged (Fig. 2B). Recently, 
we demonstrated that the two G-protein heterotrimers 
G~ol~2~" 2 and GC~od33Y4 mediate the galanin-induced inhibition 
of Ic, in RINmF5 cells [1 2]. Consequently, in a cell injected with 
anti-c%~ oligonucleotides the galanin-induced inhibition of Ica 
was reduced, however, in the same cell the somatostatin-in- 
duced inhibition of Ica was unchanged (Fig. 2A). We also com- 
pared the inhibitions of Ica induced by galanin and somato- 
statin in RINm5F cells which were injected with antisense ol- 
igonucleotides annealing to fl- and 7-subunit mRNAs. In anti- 
flrinjected cells, the somatostatin-induced inhibition of Ic, was 
decreased whereas the inhibition induced by galanin was 
not affected (Fig. 3A), The somatostatin effect remained 
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unchanged by injection of a mixture of anti-fl2 and anti-fl3 
oligonucleotides (anti-fl2 + f13) (Fig. 3B), but the galanin effect 
was suppressed in the same cells. Similarly, in cells injected with 
a mixture of antisense oligonucleotides annealing to 72- and T4- 
subunits mRNAs (anti-~, 2 + 7/4) the inhibition of Ica induced 
by somatostatin was unchanged (Fig. 3C), but the inhibition 
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Fig. 3. Somatostatin- and galanin-induced I,a inhibitions in RINm5F cells injected with antisense oligonucleotides directed against G protein ,8 and 
7 subunits. IBa traces (right) and time courses of somatostatin- and galanin-induced inhibitions of I,~ (left) in individual cells injected with anti-,8~ 
(n = 14 cells) (A), a mixture of anti-fl2 and anti-,83 (n = 8) (B), anti-73 (n = 17) (C), or a mixture of anti-y 2 and anti-y4 antisense oligonucleotides (n -- 7) 
(D) are shown. Bars denote the time span of galanin (G) or somatostatin (S) application. 
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Fig. 4. Current recordings and time courses of whole cell Ba ~+ currents 
in RINm5F cells in the presence of the somatostatin a alog NC 8-12 
and somatostatin. I  the upper panels, current traces are shown for one 
representive c ll for each agonist. Traces 1 and 4 are control currents, 
traces 2 and 5 represent Ba 2+ currents during superfusion with agonist; 
traces 3 and 6 represent currents after washing out the agonist. In the 
lower panels time courses of NC 8-12 and somatostatin-induced I , are 
shown. Numbers refer to the time points from which the traces shown 
in the upper panels have been taken. We obtained similar data in 4 cells 
for NC 8 12 and 11 cells for somatostatin. 
induced by galanin was reduced. Cells injected with anti-73 
oligonucleotides showed reduced responses to somatostatin, 
but the inhibition of Ica induced by galanin was not reduced 
(Fig. 3C). Injection of antisense oligonucleotides annealing to 
f14-, Yl-, )'5-, and ?'7- subunit mRNAs had no influence on either 
galanin- or somatostatin-induced inhibition of Ica (data not 
shown). 
These results demonstrate that the functional knock-out 
reached by injection of antisense oligonucleotides selectively 
directed against individual G-protein subunits influenced only 
the signal transduction pathway in which this particular sub- 
unit is involved. It did not touch a pathway mediated by a 
related hormonal receptor connected to the same effector sys- 
tem, i.e. voltage-gated Ca 2+ channels. 
Taken together, these results indicate that the somatostatin 
receptors in R INm5F cells use the G protein G~ozfl]?'3 to inhibit 
voltage-gated Ca 2+ channels. Thus, the somatostatin receptor 
in these cells uses the same G-protein heterotrimer to couple 
to calcium channels as the one expressed in GH 3 cells [9 11]. 
To determine which subspecies out of the five known soma- 
tostatin receptors is responsible for the inhibition of Ica in 
R INm5F cells, we used the somatostatin analog NC 8-12 which 
selectively activates the somatostatin 2 receptor (SSTR2) [16]. 
This analog inhibited Ic, in R INm5F cells with the same po- 
tency as somatostatin itself (Fig. 4), indicating that SSTR2 may 
be the receptor subtype mediating somatostatin-induced inhibi- 
tion of voltage-gated Ca 2+ channels in R INm5F cells. These 
findings are in accordance with data of Fuji et al. [17]. They 
stably transfected the human SSTR2 gene into a derivative 
RINm5F line lacking endogenous somatostatin receptor 
expression and thereby restored coupling to voltage-gated Ca 2÷ 
channels. 
Acknowledgements. We thank Rita Hauboldt for excellent echnical 
assistance, Katrin Biittner for synthesis of oligonucleotides, Dr. David 
H. Coy (New Orleans, USA) for providing the somatostatin a alog NC 
8-12. This work was supported by grants of the Deutsche 
Forschungsgemeinschaft and Fonds der Chemischen I dustrie. 
References 
[1] Law, S.L., Woulfe, D. and Reisine, T. (1995) Cell. Signalling 7, 
1-8. 
[2] Hoyer, D., Bell, G.I., Berelowitz, M., Epelbaum, J., Feniuk, W., 
Humphrey, EP.A., O'Carroll, A.-M., Patel, Y.C., Schonbrunn, 
A., Taylor, J.E. and Reisine, T. (1995) Trends Pharmacol. Sci. 16, 
86-88. 
[3] Hoyer, D., Liibbert, H. and Bruns C. (1994) Nauyn-Schmiede- 
berg's Arch. Pharmacol. 350, 441~,53. 
[4] Bell, G.I. and Reisine, T. (1993) Trends Neurosci. 16, 34~38. 
[5] Lewin, M.J.M. (1992) Annu. Rev. Physiol. 54, 455468. 
[6] Rens-Domiano, S. and Reisine, T. (1992) J. Neurochem. 58, 1987- 
1996. 
[7] Hsu, W.H., Xiang, H., Rajan, A.S., Kunze, D.L. and Boyed IIl, 
A.E. (1991) J. Biol. Chem. 266, 837 843. 
[8] Schmidt, A., Hescheler, J., Offermanns, S., Spicher, K., Hinsch, 
K.-D., Klinz, F.-J., Codina, J., Birnbaumer, L., Gausepohl, H., 
Frank, R., Schultz, G. and Rosenthal, W. (1991) J. Biol. Chem. 
266, 18025 18033. 
[9] Kleuss, C., Hescheler, J., Ewel, C., Rosenthal, W., Schultz, G. and 
Wittig, B. (1991) Nature 353, 4348. 
[10] Kleuss, C., Scheriibel, H., Hescheler, J., Schultz, G. and Wittig, 
B. (1992) Nature 358, 424426. 
[11] Kleuss, C., Schertibel, H., Hescheler, J., Schultz, G. and Wittig, 
B. (1993) Science 259, 832-834. 
[12] Kalkbrenner, F., Degtiar, V.E., Schenker, M., Brendel, S., Zobel, 
A., Hescheler, J., Wittig, B. and Schultz, G. (1995) EMBO J. 14, 
4728~,737. 
[13] Gollasch, M., Kleuss, C., Hescheler, J., Wittig, B. and Schultz, G. 
(1993) Proc. Natl. Acad. Sci. USA 90, 6265-6269. 
[14] Iyer, R.P., Egan, W., Regan, J.B. and Beaucage, S.L. (1990) J. Am. 
Chem. Soc. 112, 1253-1254. 
[15] Hamill, O.E, Marty, A., Neher, E., Sakmann, B. and Sigworth, 
F.J. (1981) Pfliigers Arch. - Eur. J. Physiol. 391, 85-100. 
[16] Rossowski, W.J. and Coy, D.H. (1994) Biochem. Biophys. Res. 
Commun. 205, 341-346. 
[17] Fuji, Y., Gonoi, T., Yamada, Y., Chihara, K., Inagaki, N. and 
Seino, S. (1994) FEBS Lett. 355, 117 120. 
